These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20709388)

  • 1. Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors.
    Nie H; Fu Y; Wang CH
    Biomaterials; 2010 Nov; 31(33):8732-40. PubMed ID: 20709388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core/shell microspheres via coaxial electrohydrodynamic atomization for sequential and parallel release of drugs.
    Nie H; Dong Z; Arifin DY; Hu Y; Wang CH
    J Biomed Mater Res A; 2010 Dec; 95(3):709-16. PubMed ID: 20725974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro.
    Xie J; Marijnissen JC; Wang CH
    Biomaterials; 2006 Jun; 27(17):3321-32. PubMed ID: 16490248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
    Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M
    Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases.
    Song S; Wientjes MG; Walsh C; Au JL
    Cancer Res; 2001 Aug; 61(16):6145-50. PubMed ID: 11507065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preparation of core/shell structured microsphere of multi first-line anti-tuberculosis drugs and evaluation of biological safety.
    Zeng H; Pang X; Wang S; Xu Z; Peng W; Zhang P; Zhang Y; Liu Z; Luo C; Wang X; Nie H
    Int J Clin Exp Med; 2015; 8(6):8398-414. PubMed ID: 26309493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
    Jang MK; Jeong YI; Nah JW
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.
    Ranganath SH; Wang CH
    Biomaterials; 2008 Jul; 29(20):2996-3003. PubMed ID: 18423584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
    Gupta B; Torchilin VP
    Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
    Emerich DF; Winn SR; Bartus RT
    Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
    Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
    Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
    Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma.
    Kumar Naraharisetti P; Yung Sheng Ong B; Wei Xie J; Kam Yiu Lee T; Wang CH; Sahinidis NV
    Biomaterials; 2007 Feb; 28(5):886-94. PubMed ID: 17067667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.